• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Novartis to present new findings of Enerzair Breezhaler at ERS congress

    PHARMABIZ

    Novartis phase III IRIDIUM study show reduced severe asthma exacerbation rates

    PHARMABIZ

    High-dose Enerzair Breezhaler further cuts asthma exacerbations

    PHARMATIMES

    Novartis Phase III IRIDIUM data in Lancet Respiratory Medicine show of Enerzair®

    PRESS RELEASE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.